Shanghai Pharmaceuticals Renews Key Procurement Agreement

Shanghai Pharmaceuticals Holding Co (HK:2607) has released an update.

Shanghai Pharmaceuticals Holding Co. has renewed its Procurement Framework Agreement with Wing Fat Printing for 2025, ensuring a steady supply of printed packaging materials for its pharmaceutical products. The agreement, valued at an annual cap of RMB90 million, aims to stabilize the company’s business operations and reduce administrative costs. This renewal highlights the company’s strategic focus on maintaining efficient supply chain partnerships.

For further insights into HK:2607 stock, check out TipRanks’ Stock Analysis page.